(Q66700992)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188%20AND%20SRC:MED&resulttype=core&format=json

23 August 2019

review article

1 reference

title

Clinical pharmacology of antihypertensive drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188%20AND%20SRC:MED&resulttype=core&format=json

23 August 2019

Clinical Pharmacology of Antihypertensive Drugs (English)

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31324-4

16 October 2022

1 reference

A. S. Nies

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A16188

16 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16188

16 October 2022

publication date

1 May 1977

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 August 2019

https://api.elsevier.com/content/article/PII:S0025712516313244?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31324-4

https://api.elsevier.com/content/article/PII:S0025712516313244?httpAccept=text/plain

16 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31324-4

Medical Clinics of North America

16 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188%20AND%20SRC:MED&resulttype=core&format=json

23 August 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188%20AND%20SRC:MED&resulttype=core&format=json

23 August 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188%20AND%20SRC:MED&resulttype=core&format=json

23 August 2019

page(s)

675-698

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188%20AND%20SRC:MED&resulttype=core&format=json

Methyldopa-Induced Decrease in Mental Activity

23 August 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Rauwolfia derivatives and breast cancer in hypertensive women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Rapid clonidine withdrawal with blood pressure overshoot exaggerated by beta-blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Side effects due to treatment of hypertension with prazosin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Effects of prazosin in patients with hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Venous constriction in response to head-up tilt in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Interaction between Clonidine and Desipramine in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Systemic hemodynamic effects of bethanidine in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Clinical pharmacology and pharmacokinetics of clonidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Minoxidil in severe hypertension: value when conventional drugs have failed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

7 January 2021

Low-renin hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Volume-dependent essential and steroid hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Role of the venous system in baroreceptor-mediated reflexes in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

The clinical pharmacology of antihypertensive drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Treatment of refractory heart failure with infusion of nitroprusside.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Acute effects of alpha-methyldopa on mean blood pressure and plasma renin activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Reserpine use in relation to breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Central nervous alpha-adrenergic receptors and the mode of action of alpha-methyldopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Studies on catecholamines, renin and aldosterone following Catapresan (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

The influences of rate of injection upon the effects of diazoxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Mechanism of exercise hypotension after sympathetic blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Evidence for a central activation of a vagal cardiodepressor reflex by clonidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Facilitation of vagal reflex bradycardia by an action of clonidine on central -receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

False adrenergic transmitters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Matched-pairs study of reserpine use and breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Nonemergency use of slow infusions of diazoxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

The essential action of propranolol in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Modification by propranolol of cardiovascular effects of induced hypoglycaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

The nature of the alpha-methyldopa red-cell antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Effects of Guanethidine and Methyldopa on a Standardized Test for Renin Responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

EFFECTS OF GUANETHIDINE, RESERPINE, AND METHYLDOPA ON REFLEX VENOUS AND ARTERIAL CONSTRICTION IN MAN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

A comparsion of the effects of prazosin and hydrallazine on blood pressure, heart rate and plasma renin activity in conscious renal hypertensive dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Beta-adrenergic receptor blocking drugs, hypertension and plasma renin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

The Importance of the Rapid Administration of Diazoxide in Accelerated Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Clinical pharmacology of propranolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Rauwolfia derivatives and breast cancer. A case/control study in Olmsted County, Minnesota

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Duration of hydralazine action in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Distribution of guanidinium antihypertensives--mechanism of their selective action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

The Relative Efficacy of Guanethidine, Methyldopa and Pargyline as Antihypertensive Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Clonidine: a new antihypertensive agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

The renin-angiotensin system (first of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Nitroprusside and Aortic Dissecting Aneurysm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Drug therapy. Sodium nitroprusside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Renal function, protein binding and pharmacological response to diazoxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Methyldopa and propranolol or practolol in moderate hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Evidence for a renal alpha-adrenergic receptor inhibiting renin release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Action of diazoxide on skeletal muscle vascular resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient Comparison

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Hydralazine elimination in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Protein Binding and Vascular Activity of Diazoxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Pharmacokinetics of bethanidine in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Beta-adrenergic receptor blocking drugs in hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Angiotensin blockade: its clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

The central action of antihypertensive drugs, mediated via central alpha-receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Beta-adrenergic receptor blockade and renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Long-term treatment of severe hypertension with minoxidil, propranolol and furosemide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Antihypertensive efficacy of a single bedtime dose of methyldopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Propranolol in hypertension: a study of long-term therapy, 1964-1970

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

Acetylator phenotype and the antihypertensive response to hydralazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

inferred from DOI database lookup

7 January 2021

based on heuristic

The relationship of plasma guanethidine levels to adrenergic blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931324-4

inferred from DOI database lookup

7 January 2021

based on heuristic

INTERACTION OF GUANETHIDINE WITH ADRENERGIC NEURONS

series ordinal

13

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31324-4

Hypotensive and renin-suppressing activities of propranolol in hypertensive patients

16 October 2022

series ordinal

42

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31324-4

Studies concerning the mechanism of suppression of renin secretion by clonidine

16 October 2022

series ordinal

71

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31324-4

16 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16188%20AND%20SRC:MED&resulttype=core&format=json

23 August 2019

1 reference